Demographics (2)
- sex - Gender of participant (phv00427660.v1.p1)
- SEX - Genetic Sex (phv00530972.v1.p1)
Geography (1)
- BODY_SITE - Body site where sample was collected (phv00427663.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00427661.v1.p1)
Other (14)
- af_status - AF status (phv00427659.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00427664.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00427654.v1.p1)
- Funding_Source - Project funding source (phv00427667.v1.p1)
- IS_TUMOR - Tumor status (phv00427665.v1.p1)
- SAMPLE_ID - Sample ID (phv00427662.v1.p1)
- SAMPLE_ID - Sample ID (phv00427657.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00427666.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00427670.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00427658.v1.p1)
- SUBJECT_ID - Subject ID (phv00427653.v1.p1)
- SUBJECT_ID - Subject ID (phv00427656.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00427668.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00427669.v1.p1)